 |
 Download PDF (460 KB) |
Steps in the EGAPP Working Group Review Process
Overview | Step 1 | Step 2 | Step 3 | Step 4
 |
Summary: EGAPP initiative products are disseminated to stakeholders through publications, web sites, and presentations.
Who is involved: CDC-based EGAPP staff, EGAPP Stakeholders Group (ESG), EGAPP Working Group (EWG).
Transparency: Stakeholder peer review, CDC clearance.
|
|
Dissemination Processes for EGAPP Products and Informational Messages
Primary EGAPP products
|
|
Secondary EGAPP products
|
Commissioned evidence reports
- Posted on EWG website or Agency for Healthcare Research and Quality website
EWG Recommendation Statements
- Published in peer-reviewed journal
- Free web access to article
- Journal may issue press release
EWG website (egappreviews.org)
|
|
Announcements of EGAPP initiative primary products and other updates (CDC-based EGAPP staff)
- Posted on the website of the CDC National Office of Public Health Genomics (NOPHG), which supports the EGAPP initiative.
- Posted on the EWG website
- Distributed by e-mail across CDC and to EGAPP stakeholder list (approximately 400 genetic testing stakeholder organizations and individuals)
EGAPP informational messages incorporated into translational materials for providers and consumers (CDC-based EGAPP staff, ESG)
CDC Press Statements related to EGAPP (CDC-based EGAPP staff and CDC press office)
- Posted on CDC web pages for Media
EGAPP initiative web pages on CDC website (CDC-based EGAPP staff)
- Posted on CDC NOPHG web pages
EGAPP initiative posters and presentations (CDC EGAPP staff, EWG, ESG) |
|
Page last updated: December 23, 2008
Page last reviewed: December 23, 2008
Content Source: EGAPP Team
|
